Cutoff Levels. The following initial test cutoff levels shall be used when screening specimens to determine whether they are negative for the five (5) drugs or classes of drugs: Initial Test Level Marijuana metabolites 100 ng/ml Cocaine metabolites 300 ng/ml Opiate metabolites 300 ng/ml Phencyclidine 25 ng/ml Amphetamines 1000 ng/ml All specimens identified as positive on the initial screening test shall be confirmed using GC/MS techniques at the cutoff levels listed below: Confirmatory Initial Test Level Marijuana metabolites* 15 ng/ml Cocaine metabolites** 150 ng/ml Opiates: Morphine 300 ng/ml Codeine 300 ng/ml Phencyclidine 25 ng/ml Amphetamines: Amphetamine 500 ng/ml Methamphetamine 500 ng/ml *Delta-9-tetrahydrocannabinol-9-cartioxylic acid **Benzoylecgonine The above cutoff levels have been established based on Department of Health and Human Services recommendations. It is understood that changes in technology and/or the need to detect the presence of other prescription or illegal drugs may necessitate the adoption of new or changed cutoff levels. Should such changes or need arise, the parties agree to meet promptly to negotiate with respect to the levels to be adopted. If no agreement is reached within sixty (60) days, the City may for good cause (e.g., NIDA or Health and Human Services recommendations) implement new or changed cutoff levels on an interim basis while negotiations are proceeding, subject to challenge by the Union through the grievance procedure.
Cutoff Levels. The Cutoff Level is the concentration limit actually used to measure urine samples. A sample which measures below the cutoff limits established by NIDA will be considered negative. A positive result shall be reported only when a shift officer/firefighter's confirmatory test reveals that one or more of the drugs listed in Section 12-2 of this Policy is present in an amount equal to or greater than the NIDA cutoff level for that drug.
Cutoff Levels. The following initial test cutoff levels shall be used when screening urine specimens to determine whether they are negative for the five (5) drugs or classes of drugs listed below: Initial Screening Level Drug Nanograms per Milliliter (ng/mL) Marijuana metabolites 50 ng/mL Cocaine metabolites 150 ng/mL Opiate metabolites 2000ng/mL Phencyclidine 25 ng/mL Amphetamines 500 ng/mL All specimens identified as positive on the initial screening test shall be confirmed using GC/MS techniques at the cutoff levels listed below: Confirmatory Level Drug Nanograms per Milliliter (ng/mL) Marijuana metabolites* 15 ng/mL Cocaine metabolites** 100 ng/mL Opiates: Morphine 2000 ng/mL Codeine 2000 ng/mL Heroin 10 ng/mL Phencyclidine (PCP) 25 ng/mL Amphetamines: Amphetamine 250 ng/mL Methamphetamine 250 ng/mL MDMA 250 ng/mL MDA 250 ng/mL MDEA 250 ng/mL * Delta-9-tetrahydrocannabinol-9-carboxylic acid ** Benzoylecgonine The above cutoff levels have been established for urine analysis based on the current Mandatory Guidelines for Federal Workplace Drug Testing Programs (published by the Substance Abuse and Mental Health Services Administrations (SAMHSA) recommendations. It is understood that changes in technology and/or the need to detect the presence of other prescription or illegal drugs may necessitate the adoption of new or changed cutoff levels. Should SAMHSA levels change, the new levels shall apply.
Cutoff Levels. Cutoff levels shall not be lower than DOT Standards. DRUG SCREENING TEST CONFIRMATION TEST Amphetamines 500 ng/mil 500 ng/mil Barbiturates 500 ng/mil 500 ng/mil Cocaine 300 ng/mil 150 ng/mil Marijuana (TCH) 100 ng/mil 15 ng/mil Opiates Group 300 ng/mil 300 ng/mil PCP 25 ng/mil 25 ng/mil Alcohol .08* .08* *The alcohol level shall be lowered to such level as may be applicable in the State of California, except as may be required un-DOT Rules and Regulations.
Cutoff Levels. If the initial drug screen test registers the following compounds at the levels listed in the middle column below, the sample provided by the Employee must be submitted to a confirmatory test. If the following compounds at the levels listed in column to the far right are found in the sample measured by GC/MS confirmation testing, such test will be considered a positive drug test. If the confirmation test reveals levels below those listed under the GC/MS column, such test will be considered negative: 17 Drug Name Initial Drug Confirmation Screen Test GC/MS Amphetamines 1000 ng/ml 500 ng/ml Cocaine 300 ng/ml 150 ng/ml Marijuana 20 ng/ml 15 ng/ml Opiates 300 ng/ml 300 ng/ml Phencyclidine (“PCP”) 25 ng/ml 25 ng/ml Benzodiazepines 300 ng/ml 150 ng/ml Methaqualone 300 ng/ml 150 ng/ml Barbiturates 300 ng/ml 150 ng/ml Methadone 300 ng/ml 150 ng/ml Propozphene 300 ng/ml 150 ng/ml The above minimum cut off level have been established based on Department of Health and Human Services recommendations it is understood that changes in technology and/or the need to detect the presence of other prescription or illegal drugs may necessitate the adoption of new or changed cutoff levels. Should such changes or need arise; the parties agree to meet promptly to negotiate with respect to the levels to be adopted. If no agreement is reached within sixty (60) days, the Board may for good cause (e. g., NIDA or Health and Human Services recommendations) implement new or changed cutoff levels on an interim basis while negotiations are proceeding, subject to challenge by the Union through grievance procedures.
Cutoff Levels. It is understood that changes in technology and/or the need to detect the presence of other prescription illegal, or legally dispensed drugs may necessitate the adoption of new or changed cutoff levels.
Cutoff Levels. The following initial test cutoff levels shall be used when screening specimens to determine whether they are negative for the five (5) drugs or classes of drugs:
